The global molecular imaging market is estimated to be USD 6,750.1 million in 2021 and is expected to witness a CAGR of 7.84% during the forecast period

Getty Images


July 11, 2022 — The"Molecular Imaging Market, by Application (Cancer, Heart Disease, Brain Disorder), by Technology (Gamma Camera, SPECT, PET, Magnetic Resonance Spectroscopy), by End User (Hospital, Diagnostic Imaging Centres), and by Region - and Forecast to 2029"report has been added to ResearchAndMarkets.com's offering.

The globalmolecular imagingmarket is estimated to be USD 6,750.1 million in 2021 and is expected to witness a CAGR of 7.84% during the forecast period.

Elderly population in emerging countries such as China and India, the adoption and advancement in technologies such asPET/CT, non-ionizing imaging techniques, and growing demand for efficient and accurate imaging systems for better and effective diagnoses of diseases are driving the global market. However, continuous improvement and innovation in molecular imaging technologies and high cost of the technologies are expected to hinder the global molecular imaging market growth.

By Technology

On the basis oftechnology, the global market is segmented into gamma cameras, single-photon emission computed tomography (SPECT), positron emission tomography (PET), magnetic resonance spectroscopy, optical imaging, andmolecular ultrasound imaging. A positron emission tomography (PET) is a non-invasive and simple technology. It delivers improved imaging data and increases patient convenience by decreasing the scanning session count, thus PET technology dominates the global market. PET as an imaging method depends on its ability to discoverchronic diseases在早期阶段。

By Application

On the basis of application, the global market is segmented into cancer, heart disease, brain disorder, gastrointestinal disorder, lung disorder, bone disorder, and others. Cancer segment accounted for the largest revenue share in the global market in 2021. Increasing occurrence of various chronic diseases such as cancer and other genetic disorders are propelling demand for early disease diagnosis eventually driving the medical imaging market growth.

By End User

根据最终用户的不同,市场分为医院、影像诊断中心和其他。在2021年的市场占有率中,医院和诊所的占有率最高。资源充足的手术室、技术熟练的医疗专业人员的出席、各种私人和团体保险的医疗保健服务覆盖范围的改善等因素都是医院占据市场主导地位的原因。

Regional Insights

North America dominated the global market in 2021 and is projected to maintain its domination during the forecast period. The reason for this market share is the increase owing to increasing healthcare aid from government and private organizations to develop technologically advanced medical systems that will help in fulfilling the demand of increasing population suffering from various diseases.

Asia Pacific market is projected to grow at a fastest CAGR during the forecast period. Trends such as growing senior population, urbanization, prevalence of chronic diseases, and demand for improved diagnostic care in the region expected to boost the regional growth.

For more information:://www.researchandmarkets.com/r/hfluyd

Related Content

Feature|Magnetic Resonance Imaging (MRI)| Christine Book

August 10, 2022 — The imaging community has lost a legend, recognized for having revolutionized the field of diagnostic ...

TimeAugust 10, 2022
arrow
House-passed Appropriations Bills Include Key Measures to Improve Nuclear Medicine Patient Safety
News|Nuclear Imaging

July 27, 2022 — Patients for Safer Nuclear Medicine, a coalition of 29 patient advocacy organizations representing ...

TimeJuly 27, 2022
arrow
the findings could be used to inform the committee on BI-RADS regarding the possible incorporation of the MBI lexicon into the BI-RADS Atlas
News|2022世界杯篮球预选赛赛程

July 21, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), understanding the likelihood of malignancy ...

TimeJuly 22, 2022
arrow
NorthStar will provide Clovis with its environmentally preferred, high purity non-carrier-added (n.c.a.) Ac-225
News|Radiopharmaceuticals and Tracers

July 20, 2022 — -NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

TimeJuly 20, 2022
arrow
Radialis Inc. today announced that it has received clearance to market the Radialis PET Imager, an organ-targeted positron emission tomography (PET) system, in the United States
News|PET Imaging

July 19, 2022 — Radialis Inc. today announced that it has received clearance to market the Radialis PET Imager, an organ ...

TimeJuly 19, 2022
arrow
Iodixanol Injection, USP is the first U.S. FDA-approved generic iso-osmolar, dimeric iodinated contrast media agent, which is used during diagnostic x-ray-based imaging such as computed tomography (CT) scans
News|Contrast Media

July 18, 2022 — Fresenius Kabi announced today it will introduce a portfolio of generic contrast media agents in the ...

TimeJuly 18, 2022
arrow
News|PET-CT

July 11, 2022 – The American Society of Nuclear Cardiology (ASNC) and the Society of Nuclear Medicine and Molecular ...

TimeJuly 11, 2022
arrow
Philips Angio CT
Sponsored Content|Case Study|SPECT-CT

A patient’s chance of recovery can be directly impacted when a diagnosis is missed or delayed. To get the right ...

TimeJuly 06, 2022
arrow
Contrast media is used to improve diagnostic imaging, and the shortage has affected millions of examinations.
News|Contrast Media

July 5, 2022 — In April 2022, a shutdown of Shanghai due to China’s “zero COVID” policy caused a global shortage of ...

TimeJuly 05, 2022
arrow
The ConformalFLASH Alliance will be the first collaboration platform between academia and industry to bring ConformalFLASH proton therapy to the clinic
News|Proton Therapy

2022年7月1日消息——IBA (Ion Beam Applications s.a., EURONEXT),全球粒子加速器技术的领导者…

TimeJuly 01, 2022
arrow
Subscribe Now